These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11365207)

  • 1. Expanded access.
    Notes Undergr; 1997 Nov; (No 36):6. PubMed ID: 11365207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded access programs.
    Treat Rev; 1997 Nov; (No 26-27):12. PubMed ID: 11364931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMP-266 and adefovir dipivoxil: 2 new AIDS drugs available to patients without treatment options.
    Baker R
    BETA; 1997 Sep; ():6-7. PubMed ID: 11364709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three drugs now in expanded access.
    Gilden D
    GMHC Treat Issues; 1997 Oct; 11(10):12. PubMed ID: 11364820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More expanded access for DMP 266.
    Vazquez E
    Posit Aware; 1998; 9(2):15. PubMed ID: 11365220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMP 266 (Sustiva) expanded access.
    Vazquez E; Whitfield L
    Posit Aware; 1997; 8(6):12. PubMed ID: 11364850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMP 266 now available.
    Gilden D
    GMHC Treat Issues; 1997 Sep; 11(9):5-6. PubMed ID: 11364751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadened access to Sustiva.
    Bornhoeft MA
    Body Posit; 1998 Jan; 11(1):13. PubMed ID: 11365007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMP 266 on the horizon.
    Vazquez E
    Posit Aware; 1997; 8(5):25. PubMed ID: 11364636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efavirenz (Sustiva) expanded access now to 400 CD4.
    AIDS Treat News; 1998 Jan; (No 286):5. PubMed ID: 11364952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efavirenz (SUSTIVA) expanded access begins October 1.
    James JS
    AIDS Treat News; 1997 Sep; (No 279):1-2. PubMed ID: 11364689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efavirenz expanded access broadened.
    Highleyman L
    BETA; 1998 Apr; ():3. PubMed ID: 11365262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New expanded access drugs for use in combination therapy.
    Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded access programs expanding.
    Proj Inf Perspect; 1997 Nov; (23):20-1. PubMed ID: 11365376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz expanded access.
    Highleyman L
    BETA; 1998 Jan; ():4. PubMed ID: 11364975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs of tomorrow.
    Posit Aware; 1998; 9(3):27-31. PubMed ID: 11365484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preveon expanded access program broadened.
    Highleyman L
    BETA; 1998 Jul; ():3. PubMed ID: 11365558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Options when HIV treatments fail.
    Treat Rev; 1998; (No 28):7-9. PubMed ID: 11365426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Don't mix Sustiva with Fortovase.
    Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efavirenz (Sustiva) may equal or exceed protease inhibitor in initial antiretroviral combination.
    James JS
    AIDS Treat News; 1998 Jul; (No 299):1-3. PubMed ID: 11365599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.